Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,851 | 402 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,571 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,562 | 50 | $0 (2024) |
| Novo Nordisk Inc | $781.63 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $541.13 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $425.73 | 25 | $0 (2024) |
| Corcept Therapeutics | $349.46 | 20 | $0 (2024) |
| Lilly USA, LLC | $316.94 | 22 | $0 (2024) |
| Amgen Inc. | $274.93 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $247.13 | 16 | $0 (2024) |
| Axsome Therapeutics, Inc. | $210.44 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,993 | 146 | ABBVIE INC. ($727.33) |
| 2023 | $1,610 | 79 | ABBVIE INC. ($280.21) |
| 2022 | $1,580 | 78 | ABBVIE INC. ($384.92) |
| 2021 | $1,668 | 99 | AstraZeneca Pharmaceuticals LP ($582.10) |
All Payment Transactions
402 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: VIROLOGY | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: VIROLOGY | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 524 | 906 | $42,245 | $9,508 |
| 2022 | 14 | 755 | 1,236 | $58,515 | $13,342 |
| 2021 | 13 | 853 | 1,464 | $70,203 | $15,599 |
| 2020 | 12 | 842 | 1,338 | $64,330 | $13,656 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 82 | 133 | $9,975 | $1,745 | 17.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 92 | 165 | $10,725 | $1,708 | 15.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 42 | 101 | $2,020 | $1,638 | 81.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 95 | 173 | $6,055 | $1,317 | 21.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 50 | 67 | $2,345 | $1,085 | 46.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 90 | $4,500 | $856.80 | 19.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 30 | 55 | $2,750 | $455.95 | 16.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 19 | 24 | $1,080 | $277.04 | 25.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 23 | 24 | $840.00 | $146.64 | 17.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 17 | 38 | $760.00 | $118.18 | 15.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 22 | 23 | $805.00 | $116.84 | 14.5% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 12 | 13 | $390.00 | $44.10 | 11.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 114 | 184 | $13,800 | $2,426 | 17.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 131 | 233 | $15,145 | $2,424 | 16.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 42 | 112 | $2,240 | $1,828 | 81.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 130 | 208 | $7,280 | $1,590 | 21.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 56 | 86 | $3,010 | $1,402 | 46.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 50 | 122 | $6,100 | $1,170 | 19.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 21 | 21 | $1,050 | $731.99 | 69.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 43 | 65 | $3,250 | $541.58 | 16.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 30 | 42 | $1,890 | $506.19 | 26.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 36 | 41 | $1,435 | $254.05 | 17.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 36 | 41 | $1,435 | $211.23 | 14.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 32 | 44 | $880.00 | $137.80 | 15.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 23 | 26 | $780.00 | $72.51 | 9.3% |
About Terry Smith, PAC
Terry Smith, PAC is a Physician Assistant healthcare provider based in Hazard, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710952585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Terry Smith, PAC has received a total of $7,851 in payments from pharmaceutical and medical device companies, with $2,993 received in 2024. These payments were reported across 402 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,851).
As a Medicare-enrolled provider, Smith has provided services to 2,974 Medicare beneficiaries, totaling 4,944 services with total Medicare billing of $52,105. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location Hazard, KY
- Active Since 02/23/2006
- Last Updated 04/07/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1710952585
Products in Payments
- MAVYRET (Drug) $929.39
- BREZTRI (Drug) $648.50
- FARXIGA (Drug) $577.59
- Ozempic (Drug) $472.33
- JARDIANCE (Drug) $425.73
- Korlym (Drug) $349.46
- TRELEGY ELLIPTA (Drug) $339.66
- AIRSUPRA (Drug) $335.73
- VRAYLAR (Drug) $281.81
- UBRELVY (Drug) $268.69
- Rybelsus (Drug) $257.26
- Otezla (Drug) $248.32
- Kerendia (Drug) $247.13
- Auvelity (Drug) $210.44
- VOQUEZNA (Drug) $190.70
- SUBLOCADE (Drug) $166.02
- MOUNJARO (Drug) $159.37
- NURTEC ODT (Drug) $154.04
- Epclusa (Drug) $125.00
- REXULTI (Drug) $124.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Hazard
Marty Mullins, Pa, PA
Physician Assistant — Payments: $55,641
Crystal Gibson, Pa C, PA C
Physician Assistant — Payments: $6,189
Sherry Miller, Pa, PA
Physician Assistant — Payments: $4,442
Beverly Neace, Pac, PAC
Physician Assistant — Payments: $790.93
Kelly Goins, Pa-C, PA-C
Physician Assistant — Payments: $630.91
Sabrina Castle, Pa-C, PA-C
Physician Assistant — Payments: $360.66